StocksDiva Bio Bin

[djmurdock]

I highly recommend you check out Antibe Therapeutics $ATBPF for an investment and trading opportunity. To put it simply, they have created a safer version of NSAIDS (Naproxen, Asprin, etc). NSAIDS are notorious for causing ulcers. To say this is a large market is an understatement. Their final Phase2b results, which is the most crucial for bios, are out in a few weeks.

Not only is their drug much safer, it is also way stronger. A double victory. Their founder, John Wallace, is one of the top gastroenterologist in the world and is highly respected in his field.
https://en.wikipedia.org/wiki/John_L._Wallace

Reasons I like the stock/company:
For the target market it is extremely undervalued.
Last Phase2B results were incredible.
Very good team, their Chairman of board is the Vice Chairman of Mastercard!
Because it is Canadian it is very under the radar in the States (undervalued)
Uplisting to Nasdaq later this year.
Fully funded for the rest of trial and rest of year
Already have licensing deals
They hired Dr. Rami Batal, from Canopy fame," in the new role of Senior VP, Commercial Strategy. The creation of this position represents a further step in the Company’s partnering efforts for its lead drug, ATB-346, and for its overall drug platform."
Stock has been beaten down from all time highs due to this Corona nightmare, providing a great entry point.
Multiple analyst give this a price target of $1.30 and higher (with good results)

Negatives:
Low volume on the US side
That's about it LOL
Like any bio in testing phases if they fail it will tank
Based on 2 years of hardcore research, I give this about a 95% of having great results and a huge partnership and/or buyout later this year.
Disclosure: I am long $ATBPF